Form 8-K - Current report:
SEC Accession No. 0001193125-21-321667
Filing Date
2021-11-05
Accepted
2021-11-05 16:31:17
Documents
15
Period of Report
2021-11-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d257036d8k.htm   iXBRL 8-K 27180
2 EX-99.1 d257036dex991.htm EX-99.1 7129
6 GRAPHIC g257036g1105234951412.jpg GRAPHIC 1721
7 GRAPHIC g257036g1105234951725.jpg GRAPHIC 2312
  Complete submission text file 0001193125-21-321667.txt   166013

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acad-20211101.xsd EX-101.SCH 2904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20211101_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20211101_pre.xml EX-101.PRE 11416
8 EXTRACTED XBRL INSTANCE DOCUMENT d257036d8k_htm.xml XML 3413
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 211385058
SIC: 2834 Pharmaceutical Preparations